Brain+ Feed

2026-02-13 16:34:28 Update on in-court restructuring proceedings - 13 February 2026

2026-02-04 17:36:20 Update on in-court restructuring proceedings - 4 February 2026 0,00 DKK | -18,18% | 0,01 MDKK

2026-01-27 13:34:27 Correction: Update on in-court restructuring proceedings - 27 January 2026 0,00 DKK | -7,14% | 0,05 MDKK

2026-01-27 13:10:40 Update on in-court restructuring proceedings - 27 January 2026 0,00 DKK | -7,14% | 0,05 MDKK

2026-01-20 20:52:33 Notice of in-court restructuring proceedings of BRAIN+ A/S 0,00 DKK | -22,73% | 0,15 MDKK

2026-01-20 10:07:06 Brain+ is seeking restructuring proceedings 0,00 DKK | -63,33% | 0,60 MDKK

2026-01-08 22:29:39 Brain+ Investor Update – December 2025 0,02 DKK | 0,00% | 0,17 MDKK

2025-12-04 12:46:19 Brain+ Investor Update - November 0,01 DKK | +4,00% | 0,02 MDKK

2025-11-19 12:24:41 Brain+ A/S updates its financial guidance for 2025 0,01 DKK | +1,96% | 0,29 MDKK

2025-11-06 15:13:50 Brain+ investor update — October 0,01 DKK | -9,23% | 0,08 MDKK

2025-10-31 08:00:00 BRAIN+ UPDATES ITS COMMUNICATION POLICY AS THE COMPANY MOVES INTO A NEW COMMERCIALISATION PHASE 0,01 DKK | +3,17% | 0,07 MDKK

2025-10-06 08:20:00 Brain+ appoints new Chief Financial Officer 0,01 DKK | -1,54% | 0,02 MDKK

2025-09-24 08:36:00 Brain+ launches first Ayla NHS pilot with one of the UK’s largest primary care practices 0,01 DKK | +4,17% | 0,11 MDKK

2025-09-16 09:21:23 Brain+ signs agreement with Agincare Homes – the fourth UK care home group to deploy effective dementia therapy with Ayla 0,01 DKK | +8,82% | 0,18 MDKK

2025-09-15 11:41:16 The Chief Financial Officer to transition, replacement search has been initiated 0,01 DKK | +9,68% | 0,08 MDKK

2025-09-04 11:58:00 Clinical pilot of Ayla based dementia therapy (CST) improves cognitive outcome by nearly 50% in care home residents 0,01 DKK | +15,79% | 0,20 MDKK

2025-09-02 09:44:00 Brain+ expands its agreement with Southcare Homes Group to deploy Ayla across the group 0,01 DKK | +1,47% | 0,02 MDKK

2025-09-01 08:41:01 Brain+ invites investors and other stakeholders to a webinar for a presentation of its Half Year 2025 report 0,01 DKK | -1,45% | 0,04 MDKK

2025-08-28 23:23:26 Brain+ publishes Half Year Report for 2025 0,01 DKK | -4,17% | 0,08 MDKK

2025-06-24 14:11:09 Brain+ A/S announces first day of trading in new shares following the TO 5 warrant exercise 0,02 DKK | -1,28% | 0,02 MDKK

2025-06-18 11:22:36 Brain+ A/S announces the outcome of its series TO 5 warrant exercise 0,02 DKK | -1,18% | 0,01 MDKK

2025-06-10 09:58:49 Brain+ A/S has received commitments to cover 100% of its TO 5 warrants, securing DKK 5.9 million in gross proceeds 0,02 DKK | -17,39% | 0,34 MDKK

2025-06-06 16:56:33 Invitation to investor webinar featuring Antony Hall: How new CST evidence and UK dementia care quality focus underscore the relevance and potential of Ayla 0,02 DKK | +66,67% | 0,34 MDKK

2025-06-06 10:51:07 New research underscores the effects of Cognitive Stimulation Therapy, supporting its role for UK care homes to comply with care quality statements 0,02 DKK | +66,67% | 0,34 MDKK

2025-06-05 11:49:44 Brain+ signs agreement with UK care home group Majesticare deploying Ayla for effective dementia care

2025-06-02 15:49:53 Brain+ A/S announces the exercise price for its warrants of series TO 5 0,02 DKK | -9,47% | 0,10 MDKK

2025-05-30 16:22:04 Brain+ A/S - Minutes of Annual General Meeting

2025-05-28 08:46:43 Brain+ A/S: Leading UK dementia care authority, Antony Hall, joins Brain+ as Strategic Advisor 0,02 DKK | -2,06% | 0,02 MDKK

2025-05-26 08:48:21 Brain+ A/S: Brain+ signs its second UK sales agreement on Ayla with Park Homes UK Group 0,02 DKK | 0,00% | 0,03 MDKK

2025-05-15 23:27:10 Brain+ A/S convenes the Annual General Meeting for 2025 0,02 DKK | -1,06% | 0,04 MDKK

2025-05-05 09:00:01 Brain+ A/S: Brain+ selected for the NHS Dementia Innovators Programme in the UK 0,02 DKK | +15,56% | 0,08 MDKK

2025-04-29 20:19:45 Brain+ A/S: Brain+ publishes its Annual Report for 2024 0,02 DKK | -4,26% | 0,01 MDKK

2025-04-16 11:15:00 Brain+ A/S: Brain+ appoints CCO Devika Wood as new CEO 0,02 DKK | +2,06% | 0,09 MDKK

2025-04-09 08:50:00 Brain+ A/S: Brain+ announces directed issue of units to convertible loan providers and guarantors 0,06 DKK | -7,09% | 0,04 MDKK

2025-04-03 08:41:48 Brain+ A/S: Contract signed with Copenhagen Municipality on extended and expanded access to Ayla 0,05 DKK | +35,00% | 0,30 MDKK

2025-04-02 08:47:12 Brain+ A/S: Brain+ announces outcome of unit rights issue 0,04 DKK | +12,99% | 0,02 MDKK

2025-03-26 08:35:00 Brain+ A/S informs of last day to subscribe in its ongoing rights issue of units 0,04 DKK | -1,68% | 0,01 MDKK

2025-03-25 12:56:36 Brain+ A/S: Brain+ to close first UK Care Home partnership contract with Southcare Homes Group 0,04 DKK | +11,18% | 0,03 MDKK

2025-03-19 14:44:35 Brain+ A/S: Invitation to investor webinar to present new Board Observer, sales pipeline progress and ongoing Unit Rights Issue 0,03 DKK | +10,74% | 0,04 MDKK

2025-03-19 08:42:11 Brain+ A/S: Brain+ expands its UK sales pipeline to €+500,000 in revenue and reveals Key Performance Indicators 0,03 DKK | +10,74% | 0,04 MDKK

2025-03-17 08:59:51 Brain+ A/S: The subscription period in Brain+' rights issue of units begins today 0,03 DKK | -10,93% | 0,05 MDKK

2025-03-11 10:54:55 Brain+ A/S: UK care sector expert, Vishal Shah joins Brain+ as Advisor and Board Observer 0,03 DKK | -1,64% | 0,07 MDKK

2025-03-10 08:31:47 Brain+ A/S: The benefits of Ayla - your CST Assistant featured in CareTech, the healthtech media for Danish healthcare professionals 0,03 DKK | +38,01% | 0,27 MDKK

2025-03-06 08:50:19 Brain+ A/S: Brain+ resolves to carry out its earlier announced unit rights issue of up to approximately DKK 16 million 0,02 DKK | -31,93% | 0,04 MDKK

2025-02-12 12:02:08 Brain+ A/S - Minutes of Extraordinary General Meeting 0,03 DKK | +6,18% | 0,03 MDKK

2025-01-30 13:47:37 Brain+ A/S: Invitation to Investor Webinar to update on sales outlook, restructuring and secured funding 0,04 DKK | +7,09% | 0,01 MDKK

2025-01-28 18:33:10 Brain+ A/S - Notice of Extraordinary General Meeting 0,04 DKK | -1,25% | 0,02 MDKK

2025-01-22 19:30:00 Brain+ A/S: Brain+ restructures to reduce OPEX by 35%, maintaining €1M ARR target for end 2025 and now expecting break-even by mid-2026, and announces 50% secured intended Rights Issue 0,04 DKK | -17,56% | 0,16 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Brain+

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden